New Delhi: The new coronavirus pressure appears to have reached far and extensive. In the newest experiences, the primary case of the brand new pressure of coronavirus has been detected within the US. According to media experiences, a younger man in his 20s from Colorado, Denver who has no journey historical past has examined optimistic for the brand new variant that was first found within the UK. The individual has been stored in isolation.
An Associated Press report says that public well being officers are investigating different potential circumstances and performing contract tracing to find out the unfold of the variant all through the state.
“There is a lot we don’t know about this new COVID-19 variant, but scientists in the United Kingdom are warning the world that it is significantly more contagious. The health and safety of Coloradans is our top priority, and we will closely monitor this case, as well as all COVID-19 indicators, very closely,” stated Governor Jared Polis.
ALSO READ: Variation In Covid-19 Strains Will Not Make Vaccines Ineffective, Says Health Ministry
Cases in India
Meanwhile, the circumstances of the mutant coronavirus have risen to 20 in India. According to info by ANI, 20 UK returnees have examined optimistic for the brand new pressure of the virus. On Tuesday, an official assertion had stated that 6 UK returnees have been discovered optimistic. Those discovered optimistic with the mutant pressure have now been stored in single room isolation and shut contacts have additionally been put below quarantine.
#COVID19: Total 20 UK returnees to India have examined optimistic for the brand new COVID pressure thus far
— ANI (@ANI) December 30, 2020
On Tuesday, Principal Scientific Advisor Okay Vijay Raghavan had stated that there isn’t any proof that present vaccines will fail to guard towards the brand new Covid-19 variant. He stated defined that almost all vaccines do goal the Spike protein wherein there are adjustments within the variants. Vaccines stimulate our immune system to supply a variety of protecting antibodies and the adjustments within the variants aren’t ample to make the vaccines ineffective.